Muscle selection for treatment of cervical dystonia with botulinum toxin - A systematic review

Parkinsonism and Related Disorders

Volumn 18, Issue 6, 2012, Pages 731-736

  Nijmeijer, S W R ^a   Koelman, J H T M ^a   Kamphuis, D J ^b   Tijssen, M A J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b REINIER DE GRAAF HOSPITAL   (Netherlands)

Author keywords

Botulinum toxin; Cervical dystonia; Efficacy; Muscle selection

Indexed keywords

BOTULINUM TOXIN;

CERVICAL DYSTONIA; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE DURATION; DISEASE SEVERITY; ELECTROMYOGRAPHY; FOLLOW UP; HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TORTICOLLIS; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; ELECTROMYOGRAPHY; HUMANS; INJECTIONS, INTRAMUSCULAR; NECK MUSCLES; TORTICOLLIS;

EID: 84862181108     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2012.04.005     Document Type: Review

References (53)

1. Jankovic J., Tsui J., Bergeron C. Prevalence of cervical dystonia and spasmodic torticollis in the United States general population. Parkinsonism Relat Disord 2007 Oct, 13(7):411-416.
2. A prevalence study of primary dystonia in eight European countries. J Neurol 2000 Oct, 247(10):787-792.
3. Lungu C., Tarulli A.W., Tarsy D., Mongiovi P., Vanderhorst V.G., Rutkove S.B. Quantifying muscle asymmetries in cervical dystonia with electrical impedance: a preliminary assessment. Clin Neurophysiol 2011 May, 122(5):1027-1031.
4. Jankovic J., Leder S., Warner D., Schwartz K. Cervical dystonia: clinical findings and associated movement disorders. Neurology 1991 Jul, 41(7):1088-1091.
5. Van Gerpen J.A., Matsumoto J.Y., Ahlskog J.E., Maraganore D.M., McManis P.G. Utility of an EMG mapping study in treating cervical dystonia. Muscle Nerve 2000 Nov, 23(11):1752-1756.
6. Deuschl G., Heinen F., Kleedorfer B., Wagner M., Lucking C.H., Poewe W. Clinical and polymyographic investigation of spasmodic torticollis. J Neurol 1992 Jan, 239(1):9-15.
7. Dressler D. Electromyographic evaluation of cervical dystonia for planning of botulinum toxin therapy. Eur J Neurol 2000 Nov, 7(6):713-718.
8. Consky E.S., Lang A.E. Clinical assessments of patients with cervical dystonia. Therapy with botulinum toxin 1994, 211-237. 2011, Marcel Dekker, Inc, New York, NY. J. Jancovic, M. Hallett (Eds.).
9. Tsui J.K., Eisen A., Stoessl A.J., Calne S., Calne D.B. Double-blind study of botulinum toxin in spasmodic torticollis. Lancet 1986 Aug 2, 2(8501):245-247.
10. Odergren T., Tollback A., Borg J. Electromyographic single motor unit potentials after repeated botulinum toxin treatments in cervical dystonia. Electroencephalogr Clin Neurophysiol 1994 Oct, 93(5):325-329.
11. Costa J., Espirito-Santo C., Borges A., Ferreira J.J., Coelho M., Moore P., et al. Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev 2005, (1). CD003633.
12. Benecke R., Dressler D. Botulinum toxin treatment of axial and cervical dystonia. Disabil Rehabil 2007 Dec 15, 29(23):1769-1777.
13. Brans J.W., de Boer I.P., Aramideh M., Ongerboer de Visser B.W., Speelman J.D. Botulinum toxin in cervical dystonia: low dosage with electromyographic guidance. J Neurol 1995 Aug, 242(8):529-534.
14. Lew M.F., Adornato B.T., Duane D.D., Dykstra D.D., Factor S.A., Massey J.M., et al. Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia. Neurology 1997 Sep, 49(3):701-707.
15. Jankovic J. Treatment of cervical dystonia with botulinum toxin. Mov Disord 2004 Mar, 19(Suppl. 8):S109-S115.
16. Brans J.W., Aramideh M., Koelman J.H., Lindeboom R., Speelman J.D., Ongerboer de Visser B.W. Electromyography in cervical dystonia: changes after botulinum and trihexyphenidyl. Neurology 1998 Sep, 51(3):815-819.
17. Ostergaard L., Fuglsang-Frederiksen A., Sjo O., Werdelin L., Winkel H. Quantitative EMG in cervical dystonia. Electromyogr Clin Neurophysiol 1996 Apr, 36(3):179-185.
18. Comella C.L., Buchman A.S., Tanner C.M., Brown-Toms N.C., Goetz C.G. Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistance. Neurology 1992 Apr, 42(4):878-882.
19. Buchman A.S., Comella C.L., Stebbins G.T., Tanner C.M., Goetz C.G. Quantitative electromyographic analysis of changes in muscle activity following botulinum toxin therapy for cervical dystonia. Clin Neuropharmacol 1993 Jun, 16(3):205-210.
20. Lee L.H., Chang W.N., Chang C.S. The finding and evaluation of EMG-guided BOTOX injection in cervical dystonia. Acta Neurol Taiwan 2004 Jun, 13(2):71-76.
21. Dubinsky R.M., Gray C.S., Vetere-Overfield B., Koller W.C. Electromyographic guidance of botulinum toxin treatment in cervical dystonia. Clin Neuropharmacol 1991 Jun, 14(3):262-267.
22. Blackie J.D., Lees A.J. Botulinum toxin treatment in spasmodic torticollis. J Neurol Neurosurg Psychiatry 1990 Aug, 53(8):640-643.
23. Tassorelli C., Mancini F., Balloni L., Pacchetti C., Sandrini G., Nappi G., et al. Botulinum toxin and neuromotor rehabilitation: an integrated approach to idiopathic cervical dystonia. Mov Disord 2006 Dec, 21(12):2240-2243.
24. Ostergaard L., Fuglsang-Frederiksen A., Werdelin L., Sjo O., Winkel H. Quantitative EMG in botulinum toxin treatment of cervical dystonia. A double-blind, placebo-controlled study. Electroencephalogr Clin Neurophysiol 1994 Dec, 93(6):434-439.
25. Stell R., Thompson P.D., Marsden C.D. Botulinum toxin in spasmodic torticollis. J Neurol Neurosurg Psychiatry 1988 Jul, 51(7):920-923.
26. Tsui J.K., Fross R.D., Calne S., Calne D.B. Local treatment of spasmodic torticollis with botulinum toxin. Can J Neurol Sci 1987 Aug, 14(3 Suppl):533-535.
27. Finsterer J., Fuchs I., Mamoli B. Quantitative electromyography-guided botulinum toxin treatment of cervical dystonia. Clin Neuropharmacol 1997 Feb, 20(1):42-48.
28. Lu C.S., Chen R.S., Tsai C.H. Double-blind, placebo-controlled study of botulinum toxin injections in the treatment of cervical dystonia. J Formos Med Assoc 1995 Apr, 94(4):189-192.
29. Tsui J.K., Eisen A., Calne D.B. Botulinum toxin in spasmodic torticollis. Adv Neurol 1988, 50:593-597.
30. Lorentz I.T., Subramaniam S.S., Yiannikas C. Treatment of idiopathic spasmodic torticollis with botulinum-a toxin: a pilot study of 19 patients. Med J Aust 1990 May 21, 152(10):528-530.
31. Brans J.W., Lindeboom R., Snoek J.W., Zwarts M.J., van Weerden T.W., Brunt E.R., et al. Botulinum toxin versus trihexyphenidyl in cervical dystonia: a prospective, randomized, double-blind controlled trial. Neurology 1996 Apr, 46(4):1066-1072.
32. Quagliato E.M., Carelli E.F., Viana M.A. A prospective, randomized, double-blind study comparing the efficacy and safety of type a botulinum toxins botox and prosigne in the treatment of cervical dystonia. Clin Neuropharmacol 2010 Jan, 33(1):22-26.
33. Brefel-Courbon C., Simonetta-Moreau M., More C., Rascol O., Clanet M., Montastruc J.L., et al. A pharmacoeconomic evaluation of botulinum toxin in the treatment of spasmodic torticollis. Clin Neuropharmacol 2000 Jul, 23(4):203-207.
34. Truong D., Duane D.D., Jankovic J., Singer C., Seeberger L.C., Comella C.L., et al. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study. Mov Disord 2005 Jul, 20(7):783-791.
35. Truong D., Brodsky M., Lew M., Brashear A., Jankovic J., Molho E., et al. Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia. Parkinsonism Relat Disord 2010 Jun, 16(5):316-323.
36. Tsui J.K., Eisen A., Mak E., Carruthers J., Scott A., Calne D.B. A pilot study on the use of botulinum toxin in spasmodic torticollis. Can J Neurol Sci 1985 Nov, 12(4):314-316.
37. Laubis-Herrmann U., Fries K., Topka H. Low-dose botulinum toxin-a treatment of cervical dystonia - a double-blind, randomized pilot study. Eur Neurol 2002, 47(4):214-221.
38. Odergren T., Hjaltason H., Kaakkola S., Solders G., Hanko J., Fehling C., et al. A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia. J Neurol Neurosurg Psychiatry 1998 Jan, 64(1):6-12.
39. Moore A.P., Blumhardt L.D. A double blind trial of botulinum toxin "A" in torticollis, with one year follow up. J Neurol Neurosurg Psychiatry 1991 Sep, 54(9):813-816.
40. Borodic G.E., Mills L., Joseph M. Botulinum A toxin for the treatment of adult-onset spasmodic torticollis. Plast Reconstr Surg 1991 Feb, 87(2):285-289.
41. Berardelli A., Carta A., Stocchi F., Formica A., Agnoli A., Manfredi M. Botulinum A toxin injection in patients with blepharospasm, torticollis and hemifacial spasm. Ital J Neurol Sci 1990 Dec, 11(6):589-593.
42. Boghen D., Flanders M. Effectiveness of botulinum toxin in the treatment of spasmodic torticollis. Eur Neurol 1993, 33(3):199-203.
43. Albanese A., Colosimo C., Carretta D., Dickmann A., Bentivoglio A.R., Tonali P. Botulinum toxin as a treatment for blepharospasm, spasmodic torticollis and hemifacial spasm. Eur Neurol 1992, 32(2):112-117.
44. Gelb D.J., Lowenstein D.H., Aminoff M.J. Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis. Neurology 1989 Jan, 39(1):80-84.
45. Borodic G.E., Pearce L.B., Smith K., Joseph M. Botulinum a toxin for spasmodic torticollis: multiple vs single injection points per muscle. Head Neck 1992 Jan, 14(1):33-37.
46. Greene P., Kang U., Fahn S., Brin M., Moskowitz C., Flaster E. Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis. Neurology 1990 Aug, 40(8):1213-1218.
47. Cordivari C., Misra V.P., Vincent A., Catania S., Bhatia K.P., Lees A.J. Secondary nonresponsiveness to botulinum toxin A in cervical dystonia: the role of electromyogram-guided injections, botulinum toxin A antibody assay, and the extensor digitorum brevis test. Mov Disord 2006 Oct, 21(10):1737-1741.
48. Tijssen M.A., Marsden J.F., Brown P. Frequency analysis of EMG activity in patients with idiopathic torticollis. Brain 2000 Apr, 123(Pt 4):677-686.
49. Tijssen M.A., Munchau A., Marsden J.F., Lees A., Bhatia K.P., Brown P. Descending control of muscles in patients with cervical dystonia. Mov Disord 2002 May, 17(3):493-500.
50. Lee I.H., Yoon Y.C., Sung D.H., Kwon J.W., Jung J.Y. Initial experience with imaging-guided intramuscular botulinum toxin injection in patients with idiopathic cervical dystonia. AJR Am J Roentgenol 2009 Apr, 192(4):996-1001.
51. Sung D.H., Choi J.Y., Kim D.H., Kim E.S., Son Y.I., Cho Y.S., et al. Localization of dystonic muscles with 18F-FDG PET/CT in idiopathic cervical dystonia. J Nucl Med 2007 Nov, 48(11):1790-1795.
52. Anderson T.J., Rivest J., Stell R., Steiger M.J., Cohen H., Thompson P.D., et al. Botulinum toxin treatment of spasmodic torticollis. J R Soc Med 1992 Sep, 85(9):524-529.
53. Werdelin L., Dalager T., Fuglsang-Frederiksen A., Regeur L., Karlsborg M., Korbo L., et al. The utility of EMG interference pattern analysis in botulinum toxin treatment of torticollis: a randomised, controlled and blinded study. Clin Neurophysiol 2011 Nov, 122(11):2305-2309.